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Tubular recoveryHeme oxygenase (HO)-1 confers transient resistance against oxidative damage, including renal ischemia-
reperfusion injury (IRI). We investigated the potential protective effect of HO-1 induction in a mouse
model of renal IRI induced by bilateral clamping of the kidney arteries. The mice were randomly assigned
to ﬁve groups to receive an intraperitoneal injection of PBS, hemin (an HO-1 inducer, 100 μmol/kg),
hemin + ZnPP (an HO-1 inhibitor, 5 mg/kg), hemin + PD98059 (a MEK-ERK inhibitor, 10 mg/kg) or a
sham operation. All of the groups except for the sham-operated group underwent 25 min of ischemia and
24 to 72 h of reperfusion. Renal function and tubular damage were assessed in the mice that received
hemin or the vehicle treatment prior to IRI. The renal injury score and HO-1 protein levels were evaluated
via H&E and immunohistochemistry staining. Hemin-preconditioned mice exhibited preserved renal cell
function (BUN: 40 ± 2 mg/dl, creatinine: 0.53 ± 0.06 mg/dl), and the tubular injury score at 72 h
(1.65 ± 0.12) indicated that tubular damage was prevented. Induction of HO-1 induced the phosphoryla-
tion of extracellular signal-regulated kinases (ERK) 1/2. However, these effects were abolished with ZnPP
treatment. Kidney function (BUN: 176 ± 49 mg/dl, creatinine: 1.54 ± 0.39 mg/dl) increased, and the tubu-
lar injury score (3.73 ± 0.09) indicated that tubular damage also increased with ZnPP treatment. HO-1-
induced tubular epithelial proliferation was attenuated by PD98059. Our ﬁndings suggest that HO-1
preconditioning promotes ERK1/2 phosphorylation and enhances tubular recovery, which subsequently
prevents further renal injury.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
HO-1 plays a cytoprotective role in the modulation of tissue
responses to injury in several pathophysiological states [1]. HO-1 is
induced in several forms of acute kidney injury (AKI), including
ischemia-reperfusion injury (IRI) [2], nephrotoxin-induced renal
injury [3], transplantation-associated tissue injury [4], acuteernal Medicine, Department of
ospital, Kaohsiung Medical
8, Taiwan.
dical Education and Research,
t Rd., Kaohsiung 81362, Taiwan.
jtseng@vghks.gov.twglomerulonephritis [5] and non-renal tissue injury [6]. Previous
studies have indicated that HO-1 is induced in the kidney by various
renal toxins or stressors, and HO-1 plays an important role in renal
protection. The ﬁrst human patient with HO-1 deﬁciency to be re-
ported suffers from growth failure, anemia, tissue iron deposition,
lymphadenopathy, leukocytosis, and an increased sensitivity to oxi-
dant injury [7]. Moreover, renal tubular injury and subsequent pro-
teinuria and hematuria are observed in patients with an HO-1
defect [8]. In an animal model of HO-1 deﬁciency, mice lacking the
gene frequently die in utero, and the animals that survive to term
display a phenotype similar to that of the HO-1-deﬁcient boy [9].
Conversely, gene transfer can induce overexpression of HO-1,
which prolongs kidney isograft survival, improves renal function
and attenuates tubular injury resulting from IRI [10]. HO-1 may
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anti-apoptotic, antioxidant and anti-autophagic effects, which have
been observed in rats and mice [11,12]. However, the molecular
mechanisms underlying the renoprotective effects of HO-1 in renal
injury have yet to be determined.
HO-1 is the rate-limiting enzyme in the degradation of heme to
iron, carbon monoxide (CO), and biliverdin [13]. HO-1 overexpres-
sion signiﬁcantly decreases apoptosis and reduces superoxide gener-
ation in myocardial IRI [14]. HO-1 induces STAT3, which modulates
phosphoinositide 3-kinase (PI3K)/PTEN in liver IRI [15]. Previous
studies have indicated that low-dose CO can impart potent anti-
inﬂammatory and cytoprotective effects through the activation of
p38 mitogen-activated protein kinase (MAPK) in lung IRI [16].
Additionally, exogenous CO suppresses the expression of proinﬂam-
matory cytokines, which may occur through downregulation of the
extracellular signal-regulated kinase (ERK) 1/2 pathway in hepatic
IRI [17]. It has been suggested that the cytoprotective effect of
HO-1 is dependent on biliverdin reductase (BVR) and the interaction
of BVR with the PI3K/Akt pathway in myocardial IRI [18]. The end
products of heme catabolism by HO-1, CO and biliverdin, also atten-
uate the tissue damage induced by IRI through activation of the
MAPK and/or PI3K/Akt pathway(s).
In the aforementioned studies, HO-1 has been found to attenuate IRI
in the heart, lung and liver through the MAPK and/or PI3K/Akt path-
way(s). However, the molecular mechanisms underlying the renal pro-
tective effects of HO-1 in renal IRI remain unclear. In this study, we
hypothesized that HO-1 exerts its renal protective effect through activa-
tion of the MAPK and/or PI3K/Akt signaling pathway(s) in a mouse
model of renal IRI. The aims of this study were to investigate whether
HO-1 preconditioning would protect the kidney from IRI and to deter-
mine themolecularmechanisms that confer this protection. In the pres-
ent study, we demonstrated that hemin preconditioning induces HO-1
protein expression, which preserves renal cell function and prevents
tubular damage in a mouse model of renal IRI. Moreover, the inductionFig. 1.HO-1 induces ERK1/2 activation in the renal tubules of hemin-treatedmice. (a) Time cour
injection. (b) Immunohistochemistry of the renal cortex labeledwith an anti-HO-1 antibody24h
ERK1/2 in the kidney cortex following hemin injection. (d) ERK1/2 phosphorylation in the renal
had no effect on HO-1 protein synthesis in the renal cortex 24 h after hemin injection. The data
each group.of HO-1 enhances tubular epithelium regeneration by activating ERK1/2
in the mouse model of renal IRI.
2. Materials and methods
2.1. Animal care and experiments
All animal experiments were performed according to a protocol
approved by the Institutional Animal Care and Use Committees of
Kaohsiung Veterans General Hospital. Eight- to ten-week-old male
BABL/c mice were used for the ischemia-reperfusion (I/R) experi-
ments. The animals were divided into ﬁve groups as follows:
(1) the sham group underwent isolation of the bilateral renal arter-
ies without clamping; (2) the vehicle group received an intraperito-
neal (i.p.) injection of 4 ml/kg PBS as a vehicle control (with IRI);
(3) the hemin-preconditioned group received hemin, a potent
inducer of HO-1, at 100 μmol/kg i.p. (Sigma-Aldrich); (4) the
hemin plus ZnPP group received zinc protoporphyrin IX, an inhibitor
of HO-1 activity, at 5 mg/kg i.p. 6 h after receiving 100 μmol/kg
hemin i.p.; and (5) the hemin plus PD98059 group received
PD98059, an inhibitor of ERK1/2 activity, at 10 mg/kg i.p. 6 h after re-
ceiving 100 μmol/kg hemin i.p. Both inhibitors were administered
i.p. 2 h before I/R, whereas hemin was administered 8 h before I/R
(Supplementary Fig. 1).
2.2. Renal ischemia-reperfusion model
Renal ischemia-reperfusion was performed as described in a re-
cent publication [19]. The mice were anesthetized with pentobarbi-
tal (50 mg/kg, i.p.), and the proximal portion of the bilateral renal
arteries was isolated and clamped with a non-traumatic microvascu-
lar clip for 25 min. Following the 25 min of ischemia, the I/R animals
were sacriﬁced 24 and 72 h after reperfusion. The sham-operated
animals underwent isolation of the bilateral renal arteries withoutse ofHO-1 andHO-2 protein synthesis in the kidney cortex following intraperitoneal hemin
after hemin injection (Scale bar, 400 μm). (c) Time course of thephosphorylation status of
cortex 24 h after hemin preconditioningwas inhibited by theHO-1 inhibitor ZnPP. (e) ZnPP
are expressed as the means± SEM. *P b 0.05 versus 0 h, #P b 0.05 versus vehicle; n= 6 in
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sciousness and were returned to their cage to recover for 24 to 72 h.
2.3. Western blot analysis
Protein extracts were separated on 10% SDS-PAGE gels and then
transferred to polyvinylidene diﬂuoride membranes (GE Healthcare,
Buckinghamshire, UK). Western blotting [20] was performed with
the appropriate anti-HO-1, anti-HO-2 (StressGen, Victoria, BC, CA),
anti-p38, anti-ERK1/2, anti-JNK1/2, anti-AKT (Cell Signaling Tech-
nology, Danvers, MA, USA), anti-PCNA (Abcam, Cambridge, UK)
and anti-β-actin (Chemicon, Temecula, CA) antibodies. The mem-
branes were subsequently incubated with an HRP-labeled goat
anti-rabbit (or mouse) secondary antibody. The membranes were
developed using the ECL-Plus detection kit (GE Healthcare). The
resultant bands were visualized and quantiﬁed with a Fuji Film
Luminescent Image Analyzer (LAS-4000, Fuji Film Co., Tokyo,
Japan) and analyzed with Multi Gauge Ver. 3.0 Image-Analysis soft-
ware (Fuji Film).
2.4. Immunohistochemistry analysis
Immunohistochemical staining [21] was performed to identify HO-1
in situ in the renal cortex of BABL/c mice. Mouse kidneys were ﬁxed
with 4% formaldehyde, and parafﬁn-embedded serial sections were
subsequently cut at a 4-μm thickness. The sections were then dewaxed,
quenched in H2O2/methanol, microwaved in citric buffer (pH 6.0),
blocked in 5% goat serum, and incubated with a speciﬁc anti-HO-1
antibody (1:200) for 1 h at room temperature (RT) on a rocking plat-
form. The sections were next incubated with a biotinylated secondaryFig. 2. Preconditioning with hemin enhanced early kidney function recovery and reduced tub
vehicle (○), and hemin (▼) groups were determined at 0, 24 and 72 h, n = 6–8 for each gro
group 24 or 72 h after IRI (Scale bar, 400 μm for left column, 100 μm for right column). (d) The tu
groups (blank bars); and for the hemin-preconditioning groups (ﬁlled bars). The data are show
blood urine nitrogen.antibody (1:200; Vector Laboratories, Burlingame, California) for 1 h
and with an AB complex (1:50) for 30 min at room temperature. The
sections were ﬁnally visualized using a DAB substrate kit (Vector Labo-
ratories) and counterstained with hematoxylin and then photographed
under an Olympus microscope equipped with a Nikon Cool Scan 995
digital camera.2.5. Histopathological examination and renal function
The kidneys were immediately ﬁxed in 10% buffered formalin for
24 h and then embedded in parafﬁn using standard procedures. The
kidneys were sectioned at a 4-μm thickness for histopathological ex-
amination, and the sections were mounted on microslides (Menzel,
Bielefeld, Germany) and kept in dry storage at room temperature.
All histopathological scoring was performed in the cortex using he-
matoxylin and eosin (H & E)-stained sections of renal tissue on
coded slides. The percentage of damaged tubules in the renal cortex
was estimated using a 5-point scale based on the following criteria:
tubular dilatation, cast deposition, brush border loss, and cellular
necrosis, in 10 randomly selected, non-overlapping ﬁelds (100×
magniﬁcation). Lesions were graded on a scale from 0 to 5: 0 = nor-
mal; 1 =mild, involvement of less than 10% of the cortex; 2 =mod-
erate, involvement of 10 to 25% of the cortex; 3 = severe,
involvement of 25 to 50% of the cortex; 4= very severe, involvement
of 50–75% of cortex; and 5 = extensive damage, involvement of
more than 75% of the cortex (Leemans et al., 2005). Serum creatinine
and blood urea nitrogen (BUN) concentrations were measured with
an automatic biochemistry analyzer to assess renal function (Vitros
950 Ortho Clinical Diagnostics, Rochester NY).ular injury following kidney IRI. Mean BUN (a) and creatinine (b) levels in the sham (●),
up. (c) H&E staining demonstrated histopathological changes in the renal cortex in each
bular injury score is shown for the sham-operated group; 24 or 72 h after IRI in the vehicle
n as themeans± SEM. *P b 0.05 versus the vehicle group; #P b 0.05 72 h versus 24 h. BUN,
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The mice were injected i.p. with 100 mg/kg of a thymidine analog,
EdU, in PBS 2 h before sacriﬁce [22]. To stain the ﬁxed sections, pieces
of the kidneywere formalin-ﬁxed, embedded in parafﬁn, and sectioned.
EdU staining was conducted using the Click-iT™ EdU imaging kit
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer's proto-
col. The sections were counterstained with Hoechst and mounted for
ﬂuorescence microscopy.
2.7. Statistical analysis
Group data are expressed as the means ± SEM. An unpaired t test
(for vehicle and experimental group comparisons) or one-way analysis
of variance (ANOVA)with Scheffe's post-hoc comparisonwas applied to
compare differences between groups. Two-way ANOVAwas conducted
to assess the effects of preconditioning and time as well as to examine
the interactions between BUN, creatinine, and the tubular injury score.
A value of P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Hemin preconditioning induces HO-1 expression in the kidney cortex
Following the i.p. administration of hemin (100 μmol/kg), the HO-1
level in the renal cortex began to increase gradually. The HO-1 level
reached its peak 24 h after hemin preconditioning. HO-1 was expressed
mainly in the renal tubules (Fig. 1a, b). The HO-2 level in the kidney did
not change following hemin preconditioning.Fig. 3.HO-1 ameliorated kidney injury following renal IRI through ERK1/2 activation. Mean BUN
n=6–8 in each group. (c) Histopathological changes in theH&E staining of the renal cortex in t
IRI. (d) Tubular injury scores of the groups 72 h after renal IRI. The data are shown as a mean ±3.2. Hemin preconditioning enhances early kidney function recovery
following kidney IRI
Eight hours after hemin preconditioning, the mice were sub-
jected to bilateral renal artery clamping for 25 min. Both the vehi-
cle and hemin-preconditioned groups exhibited tubular dilatation,
necrosis, brush border loss, and sloughing of non-necrotic tubular
cells in the tubular lumen 24 h after IRI. The tubular injury score
of the hemin-preconditioned group was slightly lower than the
score of the vehicle group 24 h after IRI. However, the vehicle and
hemin-preconditioned groups showed the same level of injury to
kidney function 24 h after IRI (Fig. 2). Two-way ANOVA was con-
ducted to examine the effects of preconditioning and time and to
investigate the interactions between BUN, creatinine, and the tu-
bular injury score (for preconditioning and condition effects). We
detected signiﬁcant effects when assessing the time effect (0, 24,
and 72 h), the preconditioning effect (sham, vehicle, and hemin
groups), and the interactions between time and preconditioning
for all of the tests.
Seventy-two hours after IRI, both BUN (40 ± 2 mg/dl, P b 0.05,
n = 6) and creatinine (0.53 ± 0.06 mg/dl, P b 0.05, n = 6) decreased
signiﬁcantly in the hemin-preconditioned group, whereas BUN and
creatinine both remained elevated in the vehicle group. The number
of dilated tubules observed in the hemin-preconditioned group was
lower than in the vehicle group. The cellularity of the renal tubular
cells in the hemin-preconditioned group was greater than the cellu-
larity in the vehicle group. The tubular injury score of the hemin-
preconditioned group was signiﬁcantly lower than that of the vehi-
cle group (3.14 ± 0.31 vs. 1.65 ± 0.12, P b 0.05, n = 8) (Fig. 2).(a) and CRE (b) levels 72 h after kidney IRI are shown for different groups in a bar graph,
he sham, vehicle, hemin, hemin plus ZnPP and hemin plus PD98059 groups 72 h after renal
SEM, *P b 0.05 versus the sham group, #P b 0.05 versus the vehicle group.
Fig. 4. HO-1 enhanced post-IRI renal tubular epithelium proliferation through ERK1/2
activation. (a) Histopathological changes and EdU labeling of the renal cortex in the vehi-
cle, hemin, and hemin plus PD98059 groups 24, 36, and 72 h after renal IRI (Scale bar,
400 μm). (b) Immunoblotting to detect PCNA expression 24 and 36 h after renal IRI in
the renal cortex of hemin-preconditioned mice as well as hemin-preconditioned mice
that received IRI PD98059, n = 6 in each group. The data are expressed as the means ±
SEM, *P b 0.05 versus the vehicle group; #P b 0.05 versus the hemin preconditioning-
only group.
2199H.-H. Chen et al. / Biochimica et Biophysica Acta 1852 (2015) 2195–22013.3. HO-1 induces ERK1/2 activation in the kidney cortex
Phosphorylated ERK1/2 in the kidney cortex increased gradually fol-
lowing i.p. hemin administration and reached peak levels 24 h after
hemin preconditioning (1.00 ± 0.18 vs. 5.77 ± 1.16 for ERK1,
P b 0.05; 0.71 ± 0.17 vs. 4.44 ± 0.89, for ERK2, P b 0.05, n = 6). The
trend of ERK1/2 activation coincided with HO-1 expression in the kid-
ney cortex (Fig. 1). However, hemin preconditioning did not alter the
phosphorylation levels of p38, JNK, and Akt (Supplementary Fig. S2).
EKR1/2 activation, which occurs 24 h after hemin preconditioning,
was blocked by the HO-1 inhibitor ZnPP, which was administered 2 h
before sacriﬁce (Fig. 1d). Nevertheless, ZnPP pretreatment had no effect
on HO-1 expression (Fig. 1e).
3.4. HO-1 enhances early kidney function recovery by activating ERK 1/2
Todeterminewhether the enhancement of kidney function recovery
associated with hemin preconditioning was the result of HO-1 expres-
sion, ZnPP (5 mg/kg) was administered to hemin-preconditioned mice
2 h before bilateral renal artery clamping. Seventy-two hours after IRI,
the kidney function of the hemin-preconditioned group had recovered
to a nearly basal level. The recovery effect induced by hemin precondi-
tioning was signiﬁcantly blocked by ZnPP. Both BUN (40 ± 2 vs. 176 ±
49, P b 0.05, n=7) and creatinine (0.53± 0.06 vs. 1.54± 0.39, P b 0.05,
n = 7) were increased in the ZnPP-treated group. In the histopatholog-
ical analysis, the renal tubules of the ZnPP-treated mice were found to
be dilated and ﬁlled with hyaline casts. The tubular injury score of the
ZnPP-treated group was signiﬁcantly elevated (1.73 ± 0.06 vs. 3.73 ±
0.09, P b 0.05, n = 7) (Fig. 3).
To test whether the HO-1 enhancement of kidney function recovery
was the result of ERK1/2 activation, PD98059 (10 mg/kg) was adminis-
tered to hemin-preconditioned mice 2 h before bilateral renal artery
clamping. The recovery effect of hemin preconditioning was markedly
blocked by PD98059. Both BUN (39.83 ± 2.33 vs. 130.12 ± 31.47,
P b 0.05, n = 7) and creatinine (0.53 ± 0.06 vs. 1.59 ± 0.33, P b 0.05,
n = 7) were elevated in the PD98059-treated group. In the histopatho-
logical analysis, the renal tubules of the PD98059-treated mice were
dilated and ﬁlled with necrotic cells. The tubular injury score of the
PD98059-treated group was signiﬁcantly elevated (1.73 ± 0.06 vs.
3.42 ± 0.12, P b 0.05, n = 7) (Fig. 3).
3.5. HO-1 enhances kidney function recovery by promoting early renal
tubular epithelium proliferation through ERK1/2 activation
To test howHO-1 enhances the recovery of kidney function under
IRI, EdU staining was performed. Twenty-four hours after IRI, the
number of EdU-positive cells began to increase in the renal cortex
of the hemin-preconditioned group, whereas EdU-positive cells
were rare in the vehicle group. Thirty-six hours after IRI, the number
of EdU-positive cells increased gradually in the renal cortex of the
vehicle group, and the group subjected to hemin preconditioning
alone exhibited many more EdU-positive cells than the vehicle
group. Seventy-two hours after IRI, the number of EdU-positive
cells remained high in the vehicle group. However, EdU labeling de-
creased in the hemin-preconditioned group 72-hours after IRI. The
augmentative effect of hemin preconditioning observed in EdU-
positive cells 24- and 36-hours after IRI was blocked by PD98059
(Fig. 4a).
To conﬁrm the proliferative effect of HO-1, PCNA expression in
the kidney cortex was measured post-IRI. Twenty-four hours
post-IRI, the PCNA level in the hemin group was marginally elevat-
ed. Thirty-six hours after IRI, the PCNA level in the hemin-
preconditioned group was signiﬁcantly elevated (4.14 ± 0.54 vs.
6.75 ± 0.67, P b 0.05, n = 6). The PCNA level was decreased by
PD98059 pretreatment (6.75 ± 0.67 vs. 2.92 ± 0.65, P b 0.05,
n = 6) (Fig. 4b).4. Discussion
In this study, our results demonstrated that the mice that were
either subjected to pre-ischemic HO-1 induction or not suffered the
same degree of IR kidney injury. However, the mice subjected to HO-1
induction showed an earlier recovery of kidney function than the
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function and histopathological recovery through activating ERK1/2,
but not p38, JNK, or Akt. By increasing the proliferation of renal tubular
epithelial cells, activated ERK1/2 could stimulate early kidney function
recovery.
The cytoprotective properties of HO-1 in the kidneywere ﬁrst recog-
nized by Nath et al. in a model of heme protein-induced AKI. HO-1 was
subsequently shown to be protective in AKI induced by cisplatin,
ischemia-reperfusion, lipopolysaccharide, and urinary tract obstruction
aswell as following renal transplantation [23]. Integration of the human
HO-1 transgene successfully rescues the phenotype of HO-1-deﬁcient
mice, including their susceptibility to nephrotoxic AKI [24]. In general,
chemically induced upregulation of HO-1 prior to the induction of IRI
results in functional and structural protection, whereas inhibition of
HO-1 activity typically abolishes the protected phenotype and often
augments injury [25]. This outcome implicates HO-1 induction as a
potential mediator of the ischemic preconditioning phenomenon [26].
Interestingly, the present study did not demonstrate that HO-1
protected kidney function in the early phase of renal IRI. The vehicle
and hemin-preconditioned groups exhibited the same level of inju-
ry to kidney function 24 h after IRI, whereas a markedly decreased
level of kidney function was observed 72 h after IRI in the hemin-
preconditioned group. These ﬁndings might suggest that HO-1 pre-
conditioning can enhance kidney function recovery. In contrast,
previous studies found no signiﬁcant differences in plasma creati-
nine between HO-1 wild-type and HO-1-deﬁcient mice in the
early phase of glycerol-induced AKI [27]. Similarly, our results sug-
gested that the mice that were either subjected to pre-ischemic
HO-1 induction or not suffered the same degree of injury in the
early phase of AKI. Additionally, Shimizu et al. reported ﬁnding
no signiﬁcant changes in serum creatinine in the early phase with
or without SnPP treatment in AKI [28]. However, our ﬁndings sug-
gested that the renoprotective effect of HO-1 may arise from
enhancement of the tubular epithelial cell recovery process.
In the present study, we found that HO-1 preconditioning improves
tubular recovery through a proliferative response induced by activated
ERK1/2, rather than through reducing kidney injury in the initial phase
of IRI. There are many studies that have demonstrated that MEK/ERK
plays an important role in protecting renal tubules from various inju-
ries. A relationship between ERK 1/2 and HO-1 has been suggested
based on an experiment involving cold ischemic injury and subsequent
rewarming in canine kidney proximal tubule cells [29]. HO-1 overex-
pression reduced the MCP-1-induced inﬂammatory response in rat
proximal tubular epithelial cells induced by ERK 1/2 activation [30].Fig. 5.The proposedmechanism of HO-1 enhancement of tubular recovery in acute kidney
injury. The HO-1/ERK1/2 signaling pathway is involved in the attenuation of renal IRI in
mice, which promotes tubular epithelial proliferation to modulate tubular damage and
enhance tubular recovery.Saﬁrstein et al. reported that inhibition of MEK/ERK using PD98059
reduced thick ascending limb cell survival by nearly fourfold following
oxidant exposure [31]. In contrast, activation of the ERK pathway by
IGF-1, or adenovirus-mediated upregulation of ERK increases proximal
tubular cell survival [31,32], whereas the IGF-1-enhanced proximal
tubular cell survival is inhibited by PD98059. An in vivo study also
demonstrated that sustained activation of the ERK1/2 pathway is a
key factor enabling continuous renal tubule repair and protection
from acute tubular necrosis in mice [33]. Similar studies have shown
that activation of ERK1/2 expression enhances tubular epithelial prolif-
eration under unilateral ureteral obstruction in AKI [34,35]. Jang et al.
also indicated that ERK contributes to recovery following ischemic inju-
ry in mouse kidneys [36]. All of these previous studies demonstrated
that MEK/ERK activation plays an important role in renal tubule protec-
tion under various stress conditions. The present study showed that
ZnPP-mediated inhibition of HO-1 activity led to a reduction of phos-
phorylated ERK1/2 and a decrease in renal tubular epithelial prolifera-
tion. In this context, ZnPP acts as a potent competitive inhibitor of
HO-1, regulating HO through a dual control mechanism in which ZnPP
potently inhibits HO enzymatic activity [37]. Therefore, inhibiting the
functions of HO-1 by ZnPP would exacerbate kidney injury. Based on
the renal tubule protection effect of ERK observed in renal IRI, it is also
reasonable to conclude that inhibiting MEK-ERK by PD98059 would
exacerbate kidney function in IRI. The present study is the ﬁrst to report
that induction of HO-1 might enhance kidney tubule recovery through
proliferative responses induced by activated ERK1/2, leading to the pro-
tective effect of HO-1 in renal IRI.
Previous studies have indicated that overexpression of HO-1
increases the expression of p21, which is a potent inhibitor of cell
proliferation [38]. p21 has been shown to inhibit the proliferation
of mouse mesangial cells, whereas inhibition of HO-1 by ZnPP
enhances cell proliferation [39]. ERK1/2 activation has been ob-
served in proliferative glomerulonephritis, and regulation of glomer-
ular cell proliferation occurs in response to immune injury [40].
However, the present study showed that induction of HO-1 in renal
tubules activated the MEK-ERK pathway, which enhanced the recov-
ery of the injured kidney by promoting the proliferation of tubular
epithelial cells. Interestingly, mesangial cell proliferation increases
with human HO-1 deﬁciency [8]. Our results are consistent with pre-
vious studies showing that the activation of ERK1/2 accelerates the
repair of tubular epithelial proliferation following kidney injury
[34–36]. The aforementioned ﬁndings suggest that HO-1 causes a re-
duction in mesangial cell proliferation but also activates ERK1/2
phosphorylation, resulting in tubular epithelial cell proliferation.
In conclusion, our study demonstrates that the induction of HO-1
is linked to ERK1/2 activation, which promotes cellular proliferation,
prevents tubular injury and enhances tubular regeneration in a mouse
model of kidney IRI (Fig. 5). These ﬁndings suggest that HO-1-mediated
preconditioning might serve as an early intervention for the pathophysi-
ology of kidney IRI and may be a potentially beneﬁcial strategy for the
prevention of AKI under clinical circumstances.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
Transparency document
The Transparency document associated with this article can be
found, in the version.
Acknowledgments
The authors thankWen-Han Cheng for technical support. This work
was supported by funding from the National Science Council, R.O.C.
2201H.-H. Chen et al. / Biochimica et Biophysica Acta 1852 (2015) 2195–2201(NSC95-2320-B-075-002; NSC95-2320-B-075B-002-MY3; NSC102-
2320-B-075B-002-MY3) to Prof. C.-J. Tseng.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.07.018.
References
[1] F.A. Wagener, J.L. da Silva, T. Farley, T. de Witte, A. Kappas, N.G. Abraham, Differen-
tial effects of heme oxygenase isoforms on heme mediation of endothelial intracel-
lular adhesion molecule 1 expression, J. Pharmacol. Exp. Ther. 291 (1999) 416–423.
[2] G.M. Goncalves, M.A. Cenedeze, C.Q. Feitoza, P.M. Wang, A.P. Bertocchi, M.J. Damiao,
H.S. Pinheiro, V.P. Antunes Teixeira, M.A. dos Reis, A. Pacheco-Silva, N.O. Camara,
The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ische-
mia and reperfusion injury, Kidney Int. 70 (2006) 1742–1749.
[3] S. Wang, Q. Wei, G. Dong, Z. Dong, ERK-mediated suppression of cilia in cisplatin-
induced tubular cell apoptosis and acute kidney injury, Biochim. Biophys. Acta
1832 (2013) 1582–1590.
[4] R. Ollinger, P. Kogler, M. Biebl, M. Sieb, R. Sucher, C. Bosmuller, J. Troppmair, W.
Mark, H. Weiss, R. Margreiter, Protein levels of heme oxygenase-1 during reperfu-
sion in human kidney transplants with delayed graft function, Clin. Transpl. 22
(2008) 418–423.
[5] P. Duann, E.A. Lianos, GEC-targeted HO-1 expression reduces proteinuria in glomer-
ular immune injury, Am. J. Physiol. Renal Physiol. 297 (2009) F629–F638.
[6] K.A. Nath, G. Balla, G.M. Vercellotti, J. Balla, H.S. Jacob, M.D. Levitt, M.E. Rosenberg,
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in
the rat, J. Clin. Invest. 90 (1992) 267–270.
[7] A. Yachie, Y. Niida, T. Wada, N. Igarashi, H. Kaneda, T. Toma, K. Ohta, Y. Kasahara, S.
Koizumi, Oxidative stress causes enhanced endothelial cell injury in human heme
oxygenase-1 deﬁciency, J. Clin. Invest. 103 (1999) 129–135.
[8] K. Ohta, A. Yachie, K. Fujimoto, H. Kaneda, T. Wada, T. Toma, A. Seno, Y. Kasahara, H.
Yokoyama, H. Seki, S. Koizumi, Tubular injury as a cardinal pathologic feature in
human heme oxygenase-1 deﬁciency, Am. J. Kidney Dis. 35 (2000) 863–870.
[9] K.D. Poss, S. Tonegawa, Reduced stress defense in heme oxygenase 1-deﬁcient cells,
Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10925–10930.
[10] T.D. Blydt-Hansen, M. Katori, C. Lassman, B. Ke, A.J. Coito, S. Iyer, R. Buelow, R.
Ettenger, R.W. Busuttil, J.W. Kupiec-Weglinski, Gene transfer-induced local heme
oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfu-
sion injury, J. Am. Soc. Nephrol. 14 (2003) 745–754.
[11] S. Bolisetty, A.M. Traylor, J. Kim, R. Joseph, K. Ricart, A. Landar, A. Agarwal, Heme
oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury, J. Am.
Soc. Nephrol. 21 (2010) 1702–1712.
[12] A.A. Shokeir, A.M. Hussein, N. Barakat, A. Abdelaziz, M. Elgarba, A. Awadalla, Activa-
tion of nuclear factor erythroid 2-related factor 2 (Nrf2) and Nrf-2-dependent genes
by ischaemic pre-conditioning and post-conditioning: new adaptive endogenous
protective responses against renal ischaemia/reperfusion injury, Acta Physiol. 210
(2014) 342–353.
[13] M.D. Maines, The heme oxygenase system: a regulator of second messenger gases,
Annu. Rev. Pharmacol. Toxicol. 37 (1997) 517–554.
[14] A.S. Pachori, L.G. Melo, L. Zhang, S.D. Solomon, V.J. Dzau, Chronic recurrent myocar-
dial ischemic injury is signiﬁcantly attenuated by pre-emptive adeno-associated
virus heme oxygenase-1 gene delivery, J. Am. Coll. Cardiol. 47 (2006) 635–643.
[15] B. Ke, X.D. Shen, H. Ji, N. Kamo, F. Gao, M.C. Freitas, R.W. Busuttil, J.W. Kupiec-
Weglinski, HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation
of TLR4 innate responses through PI3K/PTEN signaling, J. Hepatol. 56 (2012)
359–366.
[16] J. Kohmoto, A. Nakao, D.B. Stolz, T. Kaizu, A. Tsung, A. Ikeda, H. Shimizu, T. Takahashi,
K. Tomiyama, R. Sugimoto, A.M. Choi, T.R. Billiar, N. Murase, K.R. McCurry, Carbon
monoxide protects rat lung transplants from ischemia-reperfusion injury via a
mechanism involving p38 MAPK pathway, Am. J. Transplant. 7 (2007) 2279–2290.
[17] T. Kaizu, A. Ikeda, A. Nakao, A. Tsung, H. Toyokawa, S. Ueki, D.A. Geller, N. Murase,
Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon
monoxide via MEK/ERK1/2 pathway downregulation, Am. J. Physiol. Gastrointest.
Liver Physiol. 294 (2008) G236–G244.[18] A.S. Pachori, A. Smith, P. McDonald, L. Zhang, V.J. Dzau, L.G. Melo, Heme-oxygenase-
1-induced protection against hypoxia/reoxygenation is dependent on biliverdin
reductase and its interaction with PI3K/Akt pathway, J. Mol. Cell. Cardiol. 43
(2007) 580–592.
[19] C. Guo, Q.Wei, Y. Su, Z. Dong, SUMOylation occurs in acute kidney injury and plays a
cytoprotective role, Biochim. Biophys. Acta 1852 (2015) 482–489.
[20] W.H. Cheng, P.J. Lu, W.Y. Ho, C.S. Tung, P.W. Cheng, M. Hsiao, C.J. Tseng, Angiotensin
II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signal-
ing pathway to modulate central control of blood pressure, Circ. Res. 106 (2010)
788–795.
[21] W.Y. Ho, P.J. Lu, M. Hsiao, H.R. Hwang, Y.C. Tseng, M.H. Yen, C.J. Tseng, Adenosine
modulates cardiovascular functions through activation of extracellular signal-
regulated kinases 1 and 2 and endothelial nitric oxide synthase in the nucleus
tractus solitarii of rats, Circulation 117 (2008) 773–780.
[22] A. Salic, T.J. Mitchison, A chemical method for fast and sensitive detection of DNA
synthesis in vivo, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2415–2420.
[23] K.A. Nath, Heme oxygenase-1 and acute kidney injury, Curr. Opin. Nephrol.
Hypertens. 23 (2014) 17–24.
[24] J. Kim, A. Zarjou, A.M. Traylor, S. Bolisetty, E.A. Jaimes, T.D. Hull, J.F. George, F.M.
Mikhail, A. Agarwal, In vivo regulation of the heme oxygenase-1 gene in humanized
transgenic mice, Kidney Int. 82 (2012) 278–291.
[25] D.A. Ferenbach, D.C. Kluth, J. Hughes, Hemeoxygenase-1 and renal ischaemia-
reperfusion injury, Nephron Exp. Nephrol. 115 (2010) e33–e37.
[26] K.A. Nath, Heme oxygenase-1: a provenance for cytoprotective pathways in the kid-
ney and other tissues, Kidney Int. 70 (2006) 432–443.
[27] K.A. Nath, J.J. Haggard, A.J. Croatt, J.P. Grande, K.D. Poss, J. Alam, The indispensability
of heme oxygenase-1 in protecting against acute heme protein-induced toxicity
in vivo, Am. J. Pathol. 156 (2000) 1527–1535.
[28] H. Shimizu, T. Takahashi, T. Suzuki, A. Yamasaki, T. Fujiwara, Y. Odaka, M. Hirakawa,
H. Fujita, R. Akagi, Protective effect of heme oxygenase induction in ischemic acute
renal failure, Crit. Care Med. 28 (2000) 809–817.
[29] Y.S. Kwon, J.D. Foley, P. Russell, J.F. McAnulty, C.J. Murphy, Prevention of cold
ischemia/rewarming-induced ERK 1/2, p38 kinase and HO-1 activation by trophic
factor supplementation of UW solution, Cryobiology 57 (2008) 72–74.
[30] N.S. Murali, A.W. Ackerman, A.J. Croatt, J. Cheng, J.P. Grande, S.L. Sutor, R.J. Bram, G.D.
Bren, A.D. Badley, J. Alam, K.A. Nath, Renal upregulation of HO-1 reduces albumin-
driven MCP-1 production: implications for chronic kidney disease, Am. J. Physiol.
Renal Physiol. 292 (2007) F837–F844.
[31] J.F. di Mari, R. Davis, R.L. Saﬁrstein, MAPK activation determines renal epithelial cell
survival during oxidative injury, Am. J. Physiol. 277 (1999) F195–F203.
[32] I. Arany, J.K. Megyesi, H. Kaneto, S. Tanaka, R.L. Saﬁrstein, Activation of ERK or inhi-
bition of JNK ameliorates H(2)O(2) cytotoxicity in mouse renal proximal tubule
cells, Kidney Int. 65 (2004) 1231–1239.
[33] V.S. Vaidya, K. Shankar, E.A. Lock, D. Dixon, H.M. Mehendale, Molecular mechanisms
of renal tissue repair in survival from acute renal tubule necrosis: role of ERK1/2
pathway, Toxicol. Pathol. 31 (2003) 604–618.
[34] T. Masaki, R. Foti, P.A. Hill, Y. Ikezumi, R.C. Atkins, D.J. Nikolic-Paterson, Activation of
the ERK pathway precedes tubular proliferation in the obstructed rat kidney, Kidney
Int. 63 (2003) 1256–1264.
[35] B. Pat, T. Yang, C. Kong, D.Watters, D.W. Johnson, G. Gobe, Activation of ERK in renal
ﬁbrosis after unilateral ureteral obstruction:modulation by antioxidants, Kidney Int.
67 (2005) 931–943.
[36] H.S. Jang, S.J. Han, J.I. Kim, S. Lee, J.H. Lipschutz, K.M. Park, Activation of ERK
accelerates repair of renal tubular epithelial cells, whereas it inhibits progres-
sion of ﬁbrosis following ischemia/reperfusion injury, Biochim. Biophys. Acta
1832 (2013) 1998–2008.
[37] J.H. Kim, J.I. Yang, M.H. Jung, J.S. Hwa, K.R. Kang, D.J. Park, G.S. Roh, G.J. Cho, W.S.
Choi, S.H. Chang, Heme oxygenase-1 protects rat kidney from ureteral obstruction
via an antiapoptotic pathway, J. Am. Soc. Nephrol. 17 (2006) 1373–1381.
[38] P. Inguaggiato, L. Gonzalez-Michaca, A.J. Croatt, J.J. Haggard, J. Alam, K.A. Nath, Cellu-
lar overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to
apoptosis, Kidney Int. 60 (2001) 2181–2191.
[39] D. Kumar, M. Bhaskaran, L. Alagappan, D. Tori, I. Yadav, S. Konkimalla, S. Magoon,
P.C. Singhal, Heme oxygenase-1 modulates mesangial cell proliferation by p21
Waf1 upregulation, Ren. Fail. 32 (2010) 254–258.
[40] D. Bokemeyer, K.E. Guglielmi, A. McGinty, A. Sorokin, E.A. Lianos, M.J. Dunn, Activa-
tion of extracellular signal-regulated kinase in proliferative glomerulonephritis in
rats, J. Clin. Invest. 100 (1997) 582–588.
